Perceptive Xontogeny Ventures
xontogeny.comVCMatch tracks Perceptive Xontogeny Ventures as an investor focused on Biotech, Medtech, and Healthtech companies and Seed and Series A rounds. Upload your deck to compare your startup against the full private matching profile.
Check Size
Not specified
Focus Areas
Geography
Not specified
Investment Thesis
Xontogeny operates as a hands-on life sciences accelerator that partners with entrepreneurs, scientific founders and first-time CEOs to advance technologies from early development to clinical proof-of-concept. The firm combines seed capital with an experienced internal team, deep networks of industry consultants and service providers, and active operational, strategic and investment leadership to shepherd programs across modalities (therapeutics, diagnostics, devices) toward compelling clinical validation and downstream financing or commercialization.
Is Perceptive Xontogeny Ventures right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Perceptive Xontogeny Ventures is most relevant for founders raising Seed and Series A rounds in Biotech, Medtech, and Healthtech.
Focus statement
Focused exclusively on early-stage life sciences, Xontogeny invests across therapeutics, diagnostics and devices with the explicit objective of advancing programs to clinical proof-of-concept and supporting Series A venture activity (via the Perceptive Xontogeny Ventures Fund).
Value Add
- Accelerator model with active collaboration — not a purely financial investor: "We are a life sciences accelerator that collaborates with entrepreneurs, scientific founders and first-time CEOs".
- Combination of seed capital plus operational, strategic and board-level support to drive programs to clinical proof-of-concept: "seed investment capital ... with the singular goal of shepherding each program through a compelling clinical proof-of-concept study."
- Deep network of industry consultants and service providers to execute development plans.
- Team-level breadth across scientific diligence, drug and medical technology development and operations from preclinical through commercialization: "Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization."
- Close linkage to Perceptive Advisors and a venture fund vehicle (Perceptive Xontogeny Ventures Fund) to support follow-on Series A investments across biotech, medtech and healthtech.
Stage And Sector Fit
Sectors
Portfolio Highlights
Neurosterix
Biotech
Solid Biosciences
Biotech
Renovia
Medtech
Terns Pharmaceuticals
Biotech
UnLearn AI
Ai Ml
Yleana Leadership Foundation
Nonprofit
Sarepta Therapeutics
Biotech
Celgene
Biotech
+ 8 more companies in their portfolio
Ready to find your perfect investor match?
Get Started Free